TiGenix présente ses résultats de l’an 2017

NEXT STORY
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)
PREV STORY
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the ...

author_avatar
NASDAQ Market News

NewLink Genetics Receives $2.8 Million Award from DTRA to Develop a Multivalent Filovirus Vaccine

AMES, Iowa, April 15, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ)

Today on 19 December 2016 at Enzymatica's extraordinary general meeting in Lund, the meeting ...

author_avatar
NASDAQ Market News